Home > Press Releases > Saul Ewing Arnstein & Lehr Advises Supernus in Closing $450 Million Acquisition of Adamas Pharmaceuticals

Saul Ewing Arnstein & Lehr Advises Supernus in Closing $450 Million Acquisition of Adamas Pharmaceuticals

Published: 11/24/2021
Services: Mergers and Acquisitions

Washington, D.C., November 24, 2021 – Saul Ewing Arnstein & Lehr LLP served as counsel to Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) in the successful completion today of its previously announced $450 million acquisition of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS). The acquisition strengthens Supernus’ Parkinson’s disease portfolio and diversifies the company’s revenue and cash flow.

Supernus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. Adamas Pharmaceuticals delivers innovative medicines that reduce the burden of neurological diseases on patients, caregivers and society, and is focused on growing a portfolio of therapies to address a range of neurological diseases.

The Saul Ewing Arnstein & Lehr team of 20-plus attorneys was led by Mark Gruhin. George Naya and John Crozier assisted on public securities; Jay Reilly, Dennis Brennan and Michael Gold with due diligence and M&A; Charlie Monk and Doug Sampson with litigation matters; Michael Finio with Hart-Scott-Rodino (HSR) antitrust issues; Dena Calo and Lisa Koblin with employment issues; David Strosnider with employee benefits; and Stanley Kull with tax matters.

About Saul Ewing Arnstein & Lehr LLP

The attorneys of Saul Ewing Arnstein & Lehr are dedicated to providing client-centric counsel to businesses throughout the United States and internationally from 16 offices stretching down the East Coast from Boston to Miami and extending into the Midwest by way of Chicago and Minneapolis. We work with well-known private and public corporations and closely held businesses, exciting start-ups, as well as institutions of higher education, nonprofits, and governmental entities. As a full-service law firm, we handle matters involving business and finance, domestic and international tax, labor and employment, estates and trusts, litigation, real estate, intellectual property, cybersecurity and privacy, immigration, foreign investment, and bankruptcy to name a few. Energy, higher education, insurance, life sciences, technology and green space are among our core industries of focus.